Quicksilver Biosciences is a venture capital backed biotech startup based in NYC.  We are developing a versatile CMOS-integrated biosensor platform for rapid genomic identification.  Utilizing proprietary sensing techniques, Quicksilver aims to achieve target sensitivities exceeding current state-of-the-art, while doing so in a portable form-factor and at reduced cost.  We are currently operating in stealth mode...

We're Hiring!

Research and technology development at Quicksilver Biosciences is funded in part by grants from the the National Institutes of Health and the National Science Foundation.  Under the terms of our funding, our conflict of interest policy is publicly available for review.